tryptophan has been researched along with Hyperparathyroidism, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ablasser, K; Alesutan, I; Belyavskiy, E; Brussee, H; Catena, C; Fahrleitner-Pammer, A; Grübler, MR; Kolesnik, E; Lewinski, DV; März, W; Meinitzer, A; Pieske, B; Pieske-Kraigher, E; Pilz, S; Schwetz, V; Sechi, LA; Tomaschitz, A; Trummer, C; Verheyen, N; Voelkl, J | 1 |
| Christensen, MH; Lien, EA; Mellgren, G; Midttun, Ø; Nordbø, Y; Nygård, OK; Pedersen, EK; Ueland, PM; Varhaug, JE | 1 |
1 trial(s) available for tryptophan and Hyperparathyroidism, Primary
| Article | Year |
|---|---|
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Topics: Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Echocardiography; Female; Humans; Hyperparathyroidism, Primary; Inflammation; Kynurenine; Male; Quinolinic Acid; Tryptophan; Ventricular Remodeling | 2017 |
1 other study(ies) available for tryptophan and Hyperparathyroidism, Primary
| Article | Year |
|---|---|
Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Female; Humans; Hyperparathyroidism, Primary; Immunity, Cellular; Immunologic Factors; Inflammation; Interferon-gamma; Kynurenine; Longitudinal Studies; Male; Middle Aged; Monitoring, Immunologic; Neopterin; ortho-Aminobenzoates; Parathyroidectomy; Postoperative Care; Risk Factors; Tryptophan; Vitamin B 6 | 2012 |